Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Healthcare Industry News Technology News Clairity raises $43m to scale first FDA-authorized AI platform for breast cancer risk prediction Find out how Clairity’s FDA-authorized AI platform and $43M Series B funding aim to transform breast cancer risk prediction and preventive care. bySoujanya RaviNovember 13, 2025